IOVA
Iovance Biotherapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +20.0% ·
share flow +8.9% ·
net new positions +16.7%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | +5 | 196.52M | $817.32M | +8 | −3 |
| Q1 2026 | 101 | +2 | 181.45M | $636.15M | +8 | −6 |
| Q4 2025 | 98 | +1 | 178.19M | $486.45M | +1 | — |
| Q3 2025 | 14 | -2 | 98.05M | $212.78M | — | −2 |
| Q2 2025 | 13 | -2 | 89.90M | $154.64M | — | −2 |
| Q1 2025 | 12 | +2 | 25.73M | $85.68M | +2 | — |
| Q4 2024 | 10 | 0 | 23.63M | $174.86M | +2 | −2 |
| Q3 2024 | 9 | -1 | 11.04M | $103.72M | +1 | −2 |
| Q2 2024 | 10 | — | 13.79M | $110.63M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 11.04M | -9.9% | $36.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 5.97M | +1.6% | $19.88M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 5.97M | +1.6% | $19.88M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 3.51M | New | $11.69M | 0.0% | New | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 2.40M | -8.5% | $8.01M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 2.40M | -8.5% | $8.01M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.73M | +58.5% | $5.77M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.73M | +58.5% | $5.77M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 396.99K | New | $1.32M | 0.0% | New | 1 | SEC ↗ |
| 10 | Norges Bank ✦ (passive) | 260.15K | -37.5% | $866,293 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 158.32K | +109.7% | $527,216 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 119.01K | +1.4% | $396,297 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Wellington Management ✦ | 119.01K | +1.4% | $396,297 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Wellington Management ✦ | 119.01K | +1.4% | $396,297 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Wellington Management ✦ | 119.01K | +1.4% | $396,297 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 59.54K | +279.0% | $194,995 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 59.54K | +279.0% | $194,995 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 59.54K | +279.0% | $194,995 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 59.54K | +279.0% | $194,995 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 59.54K | +279.0% | $194,995 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Marshall Wace ✦ | 39.64K | -96.5% | $132,008 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 39.28K | +27.5% | $130,789 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $11.69M | 0.0% |
| Two Sigma Investments | $1.32M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 282 holders, 266.49M shares, $901.79M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.